X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The net proceeds from the private placement will be used for: completion of phase I study of ACT® in liver metastases, initiate planning and conduct supporting studies for multi-indication oncology basket trial, further development of ACT®-therapy ultrasound probe.
Lead Product(s): ACT associated Chemotherapy
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Phase IProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Undisclosed
Deal Size: $16.9 million Upfront Cash: Undisclosed
Deal Type: Private Placement July 14, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
